News

Illumina, the DNA sequencing giant whose stock has fallen 40% in two years, already had problems. Now it has to contend with Carl Icahn. The granddaddy of activist investors announced Monday morning that he’s taken […]

SAN DIEGO — The first time it happened, veteran real estate broker Ted Jacobs thought it was a fluke. But it didn’t take long for him to realize that the biotech industry’s demand for lab […]

Sanofi’s head of research and development, John Reed, is leaving the pharmaceutical giant to pursue a new opportunity, the company announced Monday. Reed joined Sanofi in 2018, after holding a similar position at Swiss pharma […]

Illumina, the largest maker of DNA sequencing technology, told investors exactly what they didn’t want to hear on Monday. For years, Illumina shares rose steadily as the company led the way on pushing down the […]

SAN DIEGO — Fate Therapeutics, a biotech upstart with big ambitions to use cell-based therapies to treat autoimmune diseases and cancer, is now planning to cut back on both jobs and experimental drugs after an […]

Biosplice’s bid to transform the treatment of everything from arthritis to cancer ran into a snag this week, with the San Diego biotech announcing that its experimental osteoarthritis drug failed to benefit patients in a […]

SAN DIEGO — After a steep drop in its stock price and with mounting competition from rivals, genomics giant Illumina on Thursday launched a new line of high-powered DNA sequencers, ratcheting up the race to […]

Is Illumina a victim of its own success? What makes the FDA change its mind? And how will petrodollars change biotech? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech […]

For Illumina, the leading maker of DNA sequencing equipment, there was bad news and worse news Tuesday. The bad news: The European Commission said it was blocking Illumina’s $8 billion acquisition of Grail, a firm […]

SAN DIEGO — From San Diego to New Jersey, biotechs developing new forms of birth control say they’re doubling down on those efforts after Roe v. Wade was overturned — even as the Supreme Court’s […]

SAN DIEGO — More than 40 years ago, Ivor Royston, a brash young assistant professor at University of California, San Diego, made an odd pitch to scientists and pharmaceutical executives across the country: Ditch your […]

Two months after being sued by Illumina over the alleged theft of trade secrets, Bay Area biotech Guardant Health fired back this week, rejecting the DNA sequencing giant’s claims and asking a federal judge to […]

San Diego biotech Halozyme announced Wednesday that it plans to buy drug development and delivery firm Antares Pharma for about $960 million. The deal, expected to go through by the first half of this year, […]

SAN DIEGO — If you’d seen him, you wouldn’t have known Scott Lippman was living through one of the most harrowing days of his 35-year career. The veteran oncologist, who directs UC San Diego’s Moores […]

DNA sequencing giant Illumina is suing Guardant Health, a firm that has become both its customer and rival, claiming that the patents at the core of Guardant’s quest to detect cancer with a simple blood […]